Protein ubiquitination and deubiquitination are central to the control of a large
number of cellular pathways and signaling networks in eukaryotes. Although the essential
roles of ubiquitination have been established in the eukaryotic DNA damage response, the
deubiquitination process remains poorly defined. Chemical probes that perturb the activity
of deubiquitinases (DUBs) are needed to characterize the cellular function of
deubiquitination. Here we report ML323 (2), a highly potent inhibitor of the USP1-UAF1
deubiquitinase complex with excellent selectivity against human DUBs, deSUMOylase,
deneddylase and unrelated proteases. Using ML323, we interrogated deubiquitination in the
cellular response to UV- and cisplatin-induced DNA damage and revealed new insights into
the requirement of deubiquitination in the DNA translesion synthesis and Fanconi anemia
pathways. Moreover, ML323 potentiates cisplatin cytotoxicity in non-small cell lung cancer
and osteosarcoma cells. Our findings point to USP1-UAF1 as a key regulator of the DNA
damage response and a target for overcoming resistance to the platinum-based anticancer
drugs.